The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the healthcare landscape . While its initial success and impact of billions in revenue , the patent expiration has opened the way for alternative medications, significantly diminishing earnings prospects . This change raises concerns